Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOMERACT 11

Application of the OMERACT Filter to Measures of Core Outcome Domains in Recent Clinical Studies of Acute Gout

William J. Taylor, David Redden, Nicola Dalbeth, H. Ralph Schumacher, N. Lawrence Edwards, Lee S. Simon, Markus R. John, Margaret N. Essex, Douglas J. Watson, Robert Evans, Keith Rome and Jasvinder A. Singh
The Journal of Rheumatology March 2014, 41 (3) 574-580; DOI: https://doi.org/10.3899/jrheum.131245
William J. Taylor
From the Department of Medicine, University of Otago, Wellington, New Zealand; Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama, USA; Department of Medicine, University of Auckland, Auckland, New Zealand; University of Pennsylvania and Veterans Affairs (VA) Medical Center, Philadelphia, Pennsylvania, USA; Department of Medicine, University of Florida, Gainesville, Florida, USA; SDG LLC, Cambridge, Massachusetts, USA; and Integrated Hospital Care Franchise, Immunology, Novartis Pharma AG, Basel, Switzerland; Pfizer Inc., New York, New York, USA; Epidemiology, Merck Sharp & Dohme Corp., Whitehouse Station, New Jersey, USA; Clinical Sciences, Regeneron Pharmaceuticals, Tarrytown, New Jersey, USA; Health & Rehabilitation Research Institute and School of Podiatry, Auckland University of Technology, Auckland, New Zealand; and Birmingham VA Medical Center and University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: will.taylor{at}otago.ac.nz
David Redden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola Dalbeth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Ralph Schumacher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Lawrence Edwards
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lee S. Simon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus R. John
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret N. Essex
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas J. Watson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Evans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith Rome
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasvinder A. Singh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Schumacher HR Jr.,
    2. Taylor W,
    3. Edwards NL,
    4. Grainger R,
    5. Schlesinger N,
    6. Dalbeth N,
    7. et al.
    Outcome domains for studies of acute and chronic gout. J Rheumatol 2009;36:2342–5.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Schlesinger N,
    2. Alten RE,
    3. Bardin T,
    4. Schumacher HR,
    5. Bloch M,
    6. Gimona A,
    7. et al.
    Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis 2012;71:1839–48.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Rome K,
    2. Frecklington M,
    3. McNair P,
    4. Gow P,
    5. Dalbeth N
    . Foot pain, impairment, and disability in patients with acute gout flares: a prospective observational study. Arthritis Care Res 2012;64:384–8.
    OpenUrlCrossRef
  4. 4.↵
    1. Dalbeth N,
    2. Zhong CS,
    3. Grainger R,
    4. Khanna D,
    5. Khanna PP,
    6. Singh JA,
    7. et al.
    Outcome measures in acute gout: a systematic literature review. J Rheumatol 2014;41:558–68.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Terwee CB,
    2. Bot SD,
    3. de Boer MR,
    4. van der Windt DA,
    5. Knol DL,
    6. Dekker J,
    7. et al.
    Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34–42.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Jaeschke R,
    2. Singer J,
    3. Guyatt GH
    . Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407–15.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Schumacher HR Jr.,
    2. Boice JA,
    3. Daikh DI,
    4. Mukhopadhyay S,
    5. Malmstrom K,
    6. Ng J,
    7. et al.
    Randomised double blind trial of etoricoxib and indomethacin in treatment of acute gouty arthritis. BMJ 2002;324:1488–92.
    OpenUrlAbstract/FREE Full Text
  8. 8.
    1. Schumacher HR,
    2. Berger M,
    3. Li-Yu J,
    4. Perez-Ruiz F,
    5. Vargas RB,
    6. Li C
    . Efficacy and tolerability of celecoxib in the treatment of moderate to extreme pain associated with acute gouty arthritis: a randomized controlled trial [abstract]. Arthritis Rheum 2010;62 Suppl 10:S151.
    OpenUrl
  9. 9.↵
    1. Reilly MC,
    2. Zbrozek AS,
    3. Dukes EM
    . The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:353–65.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 3
1 Mar 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Application of the OMERACT Filter to Measures of Core Outcome Domains in Recent Clinical Studies of Acute Gout
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Application of the OMERACT Filter to Measures of Core Outcome Domains in Recent Clinical Studies of Acute Gout
William J. Taylor, David Redden, Nicola Dalbeth, H. Ralph Schumacher, N. Lawrence Edwards, Lee S. Simon, Markus R. John, Margaret N. Essex, Douglas J. Watson, Robert Evans, Keith Rome, Jasvinder A. Singh
The Journal of Rheumatology Mar 2014, 41 (3) 574-580; DOI: 10.3899/jrheum.131245

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Application of the OMERACT Filter to Measures of Core Outcome Domains in Recent Clinical Studies of Acute Gout
William J. Taylor, David Redden, Nicola Dalbeth, H. Ralph Schumacher, N. Lawrence Edwards, Lee S. Simon, Markus R. John, Margaret N. Essex, Douglas J. Watson, Robert Evans, Keith Rome, Jasvinder A. Singh
The Journal of Rheumatology Mar 2014, 41 (3) 574-580; DOI: 10.3899/jrheum.131245
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

GOUT
OUTCOME MEASURES
PSYCHOMETRICS

Related Articles

Cited By...

More in this TOC Section

OMERACT 11

  • Updating the OMERACT Filter: Implications for Imaging and Soluble Biomarkers
  • Updating the OMERACT Filter: Implications for Patient-reported Outcomes
  • Updating the OMERACT Filter: Discrimination and Feasibility
Show more OMERACT 11

Disease-specific Outcomes I

  • Outcome Measures in Acute Gout: A Systematic Literature Review
  • OMERACT Endorsement of Measures of Outcome for Studies of Acute Gout
Show more Disease-specific Outcomes I

Similar Articles

Keywords

  • gout
  • outcome measures
  • PSYCHOMETRICS

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire